Chronic Critical Illness Patients Fail to Respond to Current Evidence‐Based Intensive Care Nutrition Secondarily to Persistent Inflammation, Immunosuppression, and Catabolic Syndrome
- 6 February 2020
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 44 (7) , 1237-1249
Abstract
Background: Sepsis‐induced multiple‐organ failure (MOF) has plagued surgical intensive care units (ICUs) for decades. Early nutrition (principally enteral) improves hospital outcomes of high‐risk ICU patients. The purpose of this study is to document how the growing epidemic of chronic critical illness (CCI) patients responds to adequate evidence‐based ICU nutrition.Methods: This retrospective post hoc subgroup analysis of an ongoing sepsis database identified 56 CCI patients who received early, adequate nutrition per an established surgical ICU protocol compared with 112 matched rapid‐recovery (RAP) patients.Results: The matched CCI and RAP groups had similar baseline characteristics. Serial biomarkers showed that CCI patients remained persistently inflamed with ongoing stress metabolism and that despite receiving evidence‐based protocol nutrition, they had persistent catabolism and immunosuppression with more secondary infections. More CCI patients were discharged to poor nonhome destinations (ie, skilled nursing facilities, long‐term acute care, hospice) (81% vs 29%, P < 0.05). At 12‐month follow‐up, CCI patients had worse functional status by Zubrod score (3.17 vs 1.62, P < 0.001) and Short Physical Battery Testing (4.78 vs 8.59, P < 0.02), worse health‐related quality of life by EQ‐5D‐3L descriptive measures (9.07 vs 7.45, P < 0.003), and lower survival (67% vs 92%, P < 0.05).Conclusions: Despite early, adequate, evidence‐based ICU nutrition, septic surgical ICU patients who develop CCI exhibit persistent inflammation, immunosuppression, and catabolism with unacceptable long‐term morbidity and mortality. Although current evidence‐based ICU nutrition may improve short‐term ICU outcomes, novel adjuncts are needed to improve long‐term outcomes for CCI patients.Keywords
This publication has 48 references indexed in Scilit:
- Novel n-3 Immunoresolvents: Structures and ActionsScientific Reports, 2013
- Quality of Life Before Intensive Care Using EQ-5DCritical Care Medicine, 2013
- Five-Year Outcomes after Oxandrolone Administration in Severely Burned Children: A Randomized Clinical Trial of Safety and EfficacyJournal of the American College of Surgeons, 2012
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls painThe FASEB Journal, 2012
- Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment toolCritical Care, 2011
- Nutritional Recommendations for the Management of SarcopeniaJournal of the American Medical Directors Association, 2010
- Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer CachexiaThe Oncologist, 2010
- Support of the metabolic response to burn injuryThe Lancet, 2004
- Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availabilityBiochemical Journal, 2003
- Reversal of Catabolism by Beta-Blockade after Severe BurnsNew England Journal of Medicine, 2001